Drugs for disorders of bone: pharmacological and clinical considerations.
D000728:Androgens / Q000627:therapeutic use; D001847:Bone Diseases / Q000188:drug therapy*; D001862:Bone Resorption / Q000187:drug effects; D002116:Calcitonin / Q000494:pharmacology / Q000627:therapeutic use; D002118:Calcium / Q000627:therapeutic use; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use; D005459:Fluorides / Q000494:pharmacology / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007700:Kinetics; D063065:Organophosphonates / Q000627:therapeutic use; D010281:Parathyroid Hormone / Q000627:therapeutic use; D010710:Phosphates / Q000494:pharmacology / Q000627:therapeutic use; D008926:Plicamycin / Q000009:adverse effects / Q000627:therapeutic use; D013431:Sulfates / Q000627:therapeutic use; D014807:Vitamin D / Q000494:pharmacology / Q000627:therapeutic use
D000728:Androgens; D002257:Carbonic Anhydrase Inhibitors; D004232:Diuretics; D004967:Estrogens; D005938:Glucocorticoids; D063065:Organophosphonates; D010281:Parathyroid Hormone; D010710:Phosphates; D013431:Sulfates; D014807:Vitamin D; D003609:Dactinomycin; D002116:Calcitonin; D008926:Plicamycin; D005459:Fluorides; D002118:Calcium